Repurposing antiviral drugs on recently emerged viral infections: A review article

K Swathi; B Nikitha; B Chandrakala; K Lakshmanadevi; M Malleswari

doi:10.1016/j.matpr.2021.03.143

Repurposing antiviral drugs on recently emerged viral infections: A review article

Mater Today Proc. 2021 Mar 31. doi: 10.1016/j.matpr.2021.03.143. Online ahead of print.

Authors

K Swathi¹, B Nikitha¹, B Chandrakala¹, K Lakshmanadevi¹, M Malleswari¹

Affiliation

¹ Institute of Pharmaceutical Technology, Sri Padmavati Mahila Visvavidyalayam, Tirupati 517502, Andhra Pradesh, India.

Abstract

Finer understandings of drugs, for newly emerged diseases are becoming difficult nowadays. The contemporary approach is Drug Repurposing. Drug repurposing implies the exploration of surviving drugs for new restorative motive. Apart from conventional drug approaches, it is a profitable, brisk and reliable approach. The equivalent therapies for newly emerging and remerging viral infections are strenuous spot these days. The drug repurposing has helped in treating many viral reprofiling infectious diseases like CoVID-19, MERS, SARS, Influenza, Swine flu, Hanta, Zika, Ebola, Marburg, Human Adeno virus infection etc. The present review looks at describing the drug repurposing approach in various viral infections.

Keywords: CoVID-19; Hanta; Marburg; Repurposing; SARS; Zika.